Literature DB >> 31656751

Method of alkalization and monitoring of urinary pH for prevention of recurrent uric acid urolithiasis: a systematic review.

Guido Maarten Kamphuis1, Jons Wouter van Hattum1, Prim de Bie2, Bhaskar K Somani3.   

Abstract

Uric acid (UA) urolithiasis comprises around 5-10% of all stones and can frequently recur. Due to the fact that UA stones form in acidic urine with a pH <5.5, these patients require special attention compared to other stone patients. The international guidelines suggest treatment and metaphylaxis by urinary alkalization. The objective of this review is to critically asses the available evidence concerning the method and efficacy of this treatment modality. A systematic review on the methods of metaphylactic therapy using oral alkalization of UA urolithiasis was conducted by two authors. Evidence was sought using a predefined search strategy in seven different databases. The provided evidence was critically evaluated using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Cochrane collaboration tool for assessing the risk of bias. Twelve manuscripts were included of which one was a randomised trial. They focussed on ways to alkalize urine and its effect on stone recurrence. Because of their methodology and heterogeneity, the evidence is presented in a narrative review. There were differences in medication used for alkalizing urine, ways of monitoring urine pH and evaluating its efficacy. The reported outcomes also differed between studies. There is currently a lack of clear evidence for the method of alkalization of urine and the method of pH measurement. Besides this, for an established treatment modality, there is lack of long term results for the alkalization therapy. In conclusion, urine alkalization is an established treatment modality for the metaphylaxis of UA urolithiasis despite the lack of evidence from high quality studies on the methods of alkalization and its treatment efficacy. The studies published on this topic are scarce and contain notable risks of bias which should be kept in mind when interpreting the stated results. 2019 Translational Andrology and Urology. All rights reserved.

Entities:  

Keywords:  Urolithiasis; alkalization; metaphylaxis; pH; uric acid (UA)

Year:  2019        PMID: 31656751      PMCID: PMC6790419          DOI: 10.21037/tau.2019.05.01

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


  29 in total

1.  Cross-over study of the influence of bicarbonate-rich mineral water on urinary composition in comparison with sodium potassium citrate in healthy male subjects.

Authors:  T Kessler; A Hesse
Journal:  Br J Nutr       Date:  2000-12       Impact factor: 3.718

2.  Dissolution of renal uric acid stones by oral alkalinization and large fluid intake in a patient suffering from gout.

Authors:  A ATSMON; A DE VRIES; J LAZEBNIK; H SALINGER
Journal:  Am J Med       Date:  1959-07       Impact factor: 4.965

Review 3.  Novel insights into the pathogenesis of uric acid nephrolithiasis.

Authors:  Naim M Maalouf; Mary Ann Cameron; Orson W Moe; Khashayar Sakhaee
Journal:  Curr Opin Nephrol Hypertens       Date:  2004-03       Impact factor: 2.894

4.  Urine pH: the effects of time and temperature after collection.

Authors:  Janine D Cook; Kathy A Strauss; Yale H Caplan; Charles P Lodico; Donna M Bush
Journal:  J Anal Toxicol       Date:  2007-10       Impact factor: 3.367

5.  Prevalence of renal uric acid stones in the adult.

Authors:  Alberto Trinchieri; Emanuele Montanari
Journal:  Urolithiasis       Date:  2017-03-03       Impact factor: 3.436

6.  Changes in stone composition over two decades: evaluation of over 10,000 stone analyses.

Authors:  Rachel Moses; Vernon M Pais; Michal Ursiny; Edwin L Prien; Nicole Miller; Brian H Eisner
Journal:  Urolithiasis       Date:  2015-02-18       Impact factor: 3.436

7.  Type 2 diabetes increases the risk for uric acid stones.

Authors:  Michel Daudon; Olivier Traxer; Pierre Conort; Bernard Lacour; Paul Jungers
Journal:  J Am Soc Nephrol       Date:  2006-06-14       Impact factor: 10.121

8.  Long-term treatment of renal lithiasis with potassium citrate.

Authors:  Francisco R Spivacow; Armando L Negri; Ana Polonsky; Elisa E Del Valle
Journal:  Urology       Date:  2010-12       Impact factor: 2.649

Review 9.  Update on the pathophysiology and management of uric acid renal stones.

Authors:  Jon-Emile S Kenny; David S Goldfarb
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

10.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.

Authors:  Larissa Shamseer; David Moher; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  BMJ       Date:  2015-01-02
View more
  3 in total

1.  Comparison potassium sodium hydrogen citrate with sodium bicarbonate in urine alkalization: a prospective crossover-controlled trial.

Authors:  Wen Xue; Jiafen Cheng; Jing Zhao; Ling Wang; Ai Peng; Xinying Liu
Journal:  Int Urol Nephrol       Date:  2022-10-19       Impact factor: 2.266

2.  Association of acidic urine pH with impaired renal function in primary gout patients: a Chinese population-based cross-sectional study.

Authors:  Yuwei He; Xiaomei Xue; Robert Terkeltaub; Nicola Dalbeth; Tony R Merriman; David B Mount; Zhe Feng; Xinde Li; Lingling Cui; Zhen Liu; Yan Xu; Ying Chen; Hailong Li; Aichang Ji; Xiaopeng Ji; Xuefeng Wang; Jie Lu; Changgui Li
Journal:  Arthritis Res Ther       Date:  2022-01-25       Impact factor: 5.156

3.  Alkalising agents in urinary tract infections: theoretical contraindications, interactions and synergy.

Authors:  Oisín N Kavanagh
Journal:  Ther Adv Drug Saf       Date:  2022-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.